Thalassaemia treatment gets EU approval
New data from Parkinson’s disease trial
Restoring the “longevity protein”
Positive topline results from phase 2 recurrent ovarian cancer trial
PDS Biotech seeking expedited approval pathway for head and neck cancer drug
Study identifies which patients benefit most from new schizophrenia drug
Mechanism behind overactive immune cells revealed
Investigational treatment of autosomal dominant polycystic kidney disease receives orphan drug designation
World’s first gene-editing therapy for hyperlipidemia
Positive results for Lilly obesity drug
“Foundational moment for in vivo cell therapy”
Cooperative motor proteins kill cancer cells when dual-inhibited